We’re collecting signatures from clinicians for this open letter. Please add your name here: Sign the letter to Wes Streeting
Mr Wes Streeting
Secretary of State for Health and Social Care
Copied to Dr Hilary Cass
3 December 2025
Dear Mr Streeting,
We are writing as a group of clinicians, academics and researchers, many of whom treat children and adults with gender-related distress, to express our grave disquiet about the PATHWAYS Trial[1], both from an ethical and a scientific point of view.
Gender-related distress in children and young people is a profound problem, and children and families need and deserve holistic support and care. Many children presenting to services have complex needs and are a particularly vulnerable group for a variety of reasons. We agree with you that the safety and wellbeing of children should be paramount, and for this reason we urge you to consider calling for the PATHWAYS Trial to be paused at least until the Data Linkage Study is completed and reported.
We appreciate that the trial has all the necessary approvals, and that you are following the advice of clinical experts. However, there is a lack of clinical and scientific consensus in this field, and professionals expressing concern about paediatric gender medicine have been marginalized, including during the development of the PATHWAYS research programme[2]. We ask that you take the time to listen to alternative views.
We think that PATHWAYS Trial is unsafe, doesn’t meet the requirements of UK clinical trial regulations[3], and should not proceed for the following reasons:
- The expected benefits do not outweigh the expected risks, jeopardising the safety and wellbeing of participants.
- Foreseeable risks to child development are not minimized.
- The trial is not scientifically sound.
- Important information from people who have already received gonadotrophin-releasing hormone analogues (GnRHa) (the Data Linkage Study) should be evaluated first.
We elaborate on these points in the annex below.
Baroness Cass called for a wide programme of research covering several aspects of gender-related distress in children and young people in her final report[4]. Other research priorities include further investigation into the causes of gender-related distress, links with co-occurring factors such as same-sex sexual orientation and autism-spectrum disorder, what kinds of psychosocial support are beneficial, what is the impact of social transition in childhood, and what are the risks and benefits of cross-sex hormone treatment in young adults. We note that research in this field is hampered by conceptual disagreements and political ‘toxicity’. The UK has the opportunity to lead the world in advancing a research programme that will start to address these disputes and forge consensus. We believe PATHWAYS in its current form will fail to grasp this opportunity.
We thank you for all the work you have done to tackle this important area of child health. We hope you will give this letter due consideration. We would be more than happy to answer any questions you might have, or to meet with you or your advisors.
Scroll down for signatures.
Annex
UK legislation governing the conduct of clinical trials (Medicines for Human Use – Clinical Trials Regulations 2004) specifies the following:
- A trial should prioritise the safety and wellbeing of participants and be initiated and continued only if the anticipated benefits justify the risks.
- A trial should not be conducted where there is a preceding belief that death or disabling injury will occur.
- A trial on children must be designed to minimise any foreseeable risk in relation to a child’s stage of development.
- The information sought must be unprocurable by other methods.
- Trials with human participants must conform to scientific principles.
Expected benefits do not outweigh the expected risks
PATHWAYS Trial is designed to address a narrow question regarding the timing of GnRHa treatment (immediate vs after 1 year) on quality of life as measured by the 10-point KIDSCREEN10 questionnaire at 2 years. This potential benefit in self-evaluated quality of life should be weighed against the substantial risks associated with GnRHa when administered during puberty: infertility (particularly when followed by cross-sex hormones), impaired development of the reproductive organs and sexual function, impaired bone development, metabolic abnormalities, and possible impairment of brain development[5]. We do not find it credible that even a substantial improvement in subjective quality of life at two years balances these risks, risks that would normally only be tolerable for potentially life-saving treatments such as chemotherapy for cancer. Furthermore, there is no evidence that links a gain in quality of life in mid-adolescence with better health and wellbeing in adulthood in this group of children, so even if this benefit is observed it gives no assurance of better long-term outcomes.
Foreseeable risks to child development are not minimized
As you are aware, GnRHa administered throughout adolescence will prevent puberty from taking place, preventing all sex steroid dependent physical and neurocognitive development from proceeding. There is no diagnostic framework for gender incongruence that has good predictive value for who will persist through adolescence into adulthood, and who will experience resolution of gender-related distress. The ICD 11 diagnostic criteria[6], used in PATHWAYS, are based around a set of highly subjective preferences linked to sex-role stereotypes. It is not therefore possible to reliably select only the children who might stand to benefit from GnRHa for the trial and exclude those who will not benefit. This means that inevitably children will be harmed in this trial who could not possibly derive any benefit from the treatment.
Furthermore, there is good reason to consider that puberty suppression is an important factor in preventing resolution of gender-related distress in some children: the high proportion of children progressing to cross-sex hormones after GnRHa in several cohorts suggests this[7]. The PATHWAYS Trial does not acknowledge this critical difficulty with selecting participants, nor will it investigate a possible causal link between GnRHa and persistence of gender-related distress. These considerations, we believe, add further weight to ethical concerns regarding this trial[8].
The trial is not scientifically sound
We understand the calls for evidence to help guide children, families, clinicians and policy makers in this very difficult field, but PATHWAYS Trial is not capable of delivering evidence that will help to resolve any of the disputes around the efficacy and safety of GnRHa. We are happy to provide a more detailed critique of the protocol, but in short:
- There is no clear research question grounded in a hypothesis about how puberty suppression might help children with gender-related distress.
- The comparison of immediate start of GnRHa versus delayed start at 12 months with follow up only to 24 months means that no reliable data on the benefit of GnRHa will be generated, and data about safety will be limited.
- There is no randomised control group to allow a reliable comparison. The planned comparison with a subgroup from PATHWAYS Horizon Intensive will not provide a reliable control, as this group will be too different from the group in Trial.
- Children from Tanner stage 2 to Tanner stage 5 will be included, but there is no acknowledgement that the use of GnRHa at these extremes of pubertal development constitutes a radically different intervention, with different potential benefits and a very different risk profile. This will hamper interpretation of the results.
Other important data should be analysed first
The Data Linkage Study was halted due to the non-cooperation of the adult gender clinics in the last phase of the Cass Review, and was subsequently passed over to NHSE for completion. This dataset will be the largest of its kind in the world, and while it cannot give us definitive information about whether or not GnRHa is beneficial, it can give us critical information about safety. While we understand the urgency to proceed with a research programme to meet the needs of this group of children, we think it is indefensible to proceed with a trial that exposes more children to the risks of GnRHa without first looking at what has happened to people who have already received this drug. The DLS will hopefully tell us about persistence and desistance rates, physical and mental health in the medium term, mortality, and could start to give us some indicators of important long-term outcomes like sexual function and fertility. If the DLS gives a strong safety signal, for example demonstrating excess mortality in people who have been given GnRHa, and PATHWAYS Trial has gone ahead, public trust in our medical research institutions could be undermined.
Although GnRHa is a well-studied class of drugs, in the treatment of certain pathological conditions, the effects of administration to physiologically healthy children, throughout adolescence, halting puberty into adulthood, are far from being well understood. We believe further pre-clinical (animal) testing could be helpful in characterising the safety profile, and is far preferable from an ethical perspective.
Scroll down for signatures
Footnotes
[2] For links to relevant parts of legislation and the roles of the various regulators and oversight bodies see March 2025 Letter from Clinical Advisory Network on Sex and Gender to trial investigators, oversight board and regulators outlining ethical concerns.
[3] UK Policy Framework for Health and Social Care Research; Medicines for Human Use (Clinical Trials) Regulations 2004
[4] Recommendation 6, p 35, The Cass Review Final Report
[5] For up-to-date references in the published literature on GnRHa see US Dept of Health and Human Services (HHS) report Treatment for Pediatric Gender Dysphoria Review of Evidence and Best Practices, sections 5.3, 7.1, 7.2 and 7.3.
[6] ICD 11 Gender Incongruence
[7] Carmichael, P., Butler, G., Masic, U., Cole, T. J., De Stavola, B. L., Davidson, S., Skageberg, E. M., Khadr, S., & Viner, R. M. (2021). Short-term outcomes of pubertal suppression in a selected cohort of 12 to 15 year old young people with persistent gender dysphoria in the UK. PLOS ONE 16 (2).
Wiepjes, C.M., Nota, N.M., de Blok, C.J.M., Klaver, M., de Vries, A.L.C., Wensing-Kruger, S.A., de Jongh, R.T., Bouman, M.B., Steensma, T.D., Cohen-Kettenis, P., Gooren, L.J.G., Kreukels, B.P.C. & den Heijer, M. (2018). The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): Trends in Prevalence, Treatment, and Regrets. Journal of Sexual Medicine 15 (4). de Vries, A.L.C., Steensma, T.D., Doreleijers, T.A. & Cohen-Kettenis, P.T. (2011). Puberty suppression in adolescents with gender identity disorder: a prospective follow-up study. J Sex Med 8 (8): 2276-83.
[8] For detailed discussion of ethics see Article by Dr David Bell and Dr Sinead Helyar Would a Puberty Blocker Trial be Ethical? See also HHS report section 13.4.1 on research ethics.
Add your name here: Sign the letter to Wes Streeting
Yours sincerely,
These are the signatories that agreed to their names being made public; the letter sent to Wes Streeting contains a significant number who did not want to be public. Signatory list updated 14 January 2016
Doctors and Surgeons
Dr Louise Irvine, MB ChB MRCGP DRCOG MSc retired GP Co-chair Clinical Advisory Network on Sex and Gender (CAN-SG)
Dr Stella Kingett, MBBS MRCPsych DPMSA Consultant Psychiatrist, Co-chair CAN-SG
Dr Aileen O’Brien Consultant Psychiatrist and Reader in Psychiatry
Dr Juliet Singer MRCPsych Consultant Child and Adolescent Psychiatrist
Dr Lucy Grain MBChB FRCPCH Consultant Paediatrician
Dr Shahana Hussain MRCPsych Consultant Child & Adolescent Psychiatrist
Dr Pamela Yerassimou MB BS MRCPsych Consultant Psychiatrist
Dr Tessa Katz MRCGP General Practitioner
Dr Ellen Wright MBBS MSc FRCGP GP Clinical Academic Fellow, King’s College London
Dr David Bell, Retired Consultant Psychiatrist and Psychoanalyst
Dr Sarah Thurlbeck MBBS MRCP FRCPC Consultant Paediatrician (retired) and former Named Doctor for Child Safeguarding
Ms Sheila Stallard MD, FRCS retired Consultant Surgeon
Dr Jane Martin, MD MRCPsych retired Consultant Psychiatrist
Dr Seth Bhunnoo MBBS BSc MA MRCPsych PhD Consultant Psychiatrist
Dr Maria Atkins Retired Consultant Psychiatrist Former Lead for Wales and Vice President Royal College Psychiatrists
Dr Lenny Cornwall MD FRCPsych FFMLM Consultant Psychiatrist
Doctor Christopher Verity Past Vice President, Royal College of Paediatrics and Child Health Retired Consultant Paediatric Neurologist
Dr Gwenllian Boddington, Psychiatry Core Trainee
Dr Nicola Anne Cowan, MBChB MRCPsych, Consultant Psychiatrist (Retired)
Dr Rae Elizabeth Webster MBChB LLB(Hons) FRCA FFICM MBA Consultant in Intensive Care & Anaesthesia (rtd)
Dr Chris Holdridge MRCGP MBBS BA AKC General practitioner
Dr Josanne Holloway MB CHB FRCPsych Consultant Forensic Psychiatrist
Dr Kiran Sharma, MBBS, General Practitioner
Dr Caroline Scherf MD FRCOG DCoSRH Gynaecologist
Dr Alice Hodkinson, MRCGP General Practitioner MA Medical Ethics and Law
Dr Katharine Townsend MBBS MRCGP General Practitioner
Dr C Silver BA MA(Cantab) BMBS General Practitioner
Dr H Suffling BSc (Hons) MBChB MRCPsych Consultant Psychiatrist
Dr Ruth Livingstone BM BA DRCOG GP/Clinical Governance Lead (rtd)
Dr Matthew Train FRCR Consultant Radiologist
Dr Daiva Barzdaitiene Consultant Psychiatrist
Dr Katie Clyde MRCPsych Consultant Psychiatrist
Dr V Venning General Practitioner
Dr Gillian Moss MSc MRCPsych Retired Consultant Psychiatrist
Dr Natalie Roberts D Clin Psych Consultant Clinical Psychologist
Dr Julie Maxwell MBBCh MRCPCH Rtd Community Paediatrician
Dr Judith Dodds BMBSc DFRH Community Paediatrician (rtd)
Dr C Silver BA, MA (Cantab) BMBS General Practitioner
Dr Richard Fry MD MRCPsych MSc Consultant Integrative Child and Adolescent Psychiatrist
Dr Anne Williams MRCGP DCH DRCOG MA Bioethics General Practitioner
Dr Jennifer Cunningham Retired Community Paediatrician
Dr Rhian Jones General practitioner
Dr L Dealwis General Practitioner
Dr A Laskor General Practitioner
Dr Anne Miners MRCGP General Practitioner – retired
Dr Helen Simmons Consultant Child & Adolescent Psychiatrist
Dr Liam Hughes MBBS FRCP MD Retired Consultant Cardiologist
Dr Isobel Ross MB, ChB, FANZCA, PhD (Otago) Retired Anaesthetist
Dr Louise Kirby MBBS(Hons1) UNSW FRACGP GP counsellor
Dr Kerrie MacDonald MBBS (UNSW),1974, FRACP Paediatrician
Dr Ben Symon MBBS FRACP PEM Paediatric Emergency Physician
Dr Emma Hayward MBChB FRCGP GP
Dr Jonathan Veitch MBChB FRCA Consultant Anaesthetist
Dr I Hussain GP
Dr P Vincent MB BS BSc MRCGP GP
Dr David Randall MBBS PhD Consultant nephrologist
Dr Alan Belbin Retired GP
Dr Vivien Ireland MbChb MRCGP DObstRCOG Retired General Practitioner
Dr Benjamin Williams MRCPsyc PhD Consultant General Adult Psychiatrist
Dr Michael Blackmore MB, BS, DipObst RCOG Retired General Practitioner
Dr Mark Anderson BSc BMedSci BM BS MRCPCH Consultant Paediatrician
Dr Hugo Van Woerden Doctor
Dr Kieran M Grey MBChB(hons), MRCGP GP
Dr Geoffrey Hollier M.B., B.S. Retired GP
Dr Sara Woolder BMBS MRCGP DRCOG GP, retired
Dr M Balsitis MBChB, MRCPath, DipFMS Retired Medical Doctor
Dr Brenda Mallett MBBS MRCGP DRCOG PGCert [clinical Medicine] Retired GP Principal
Dr Elizabeth Evans Retired Doctor
Dr Richard Booker FIMC RCS Edin GP
Dr Susan Hunt MBChB General Practitioner (Retired)
Dr Ranjini Mohan MBBS, MRCPCH Paediatrician
Dr Elizabeth Jones MRCP, DCH Community Paediatrician (retired)
Dr James Dyson MRCS, LRCP, MA Retired GP with special interest and 30+ years of experience school doctoring
Dr Richard Watson MRCGP General Practitioner. Lanarkshire.
Dr Tara Watson BM DCH MRCFP GP
Dr Diana Clayton MD, PhD Consultant Physician Endocrinologist
Dr Simon Barker MD Paediatric Orthopaedic Surgeon
Dr John Carter MA, FRCA Retired NHS Consultant, Anaesthetics and Intensive Care
Dr Natalia Barry MBBS, MA emergency medicine and health care leadership UCLMS and LGT Emergency Medicine Consultant
Dr Carine Minne Consultant Psychiatrist & Psychoanalyst
Dr B A Reay MBChB Retired hospital doctor
Mr Richard Turnock MBChB FRCS (Paediatric Surgery) (Retired) Consultant Paediatric Surgeon
Dr G Harverson MRCP(Lond), FRCR, DTM&H Consultant Radiologist (rtd)
Dr Alan Mordue MB ChB, FFPH (ret). Retired Consultant in Public Health Medicine
Dr Dominika Murgasova MSc MD MRCPCH Paediatrician
Dr Angharad Gray MA MBBCh MSc Specialist community psychiatrist
Dr Sheila Matthews MB ChB MSc (Community Paediatrics) Retired GP
Dr Francis Sansbury MRCPCH MRCP(UK) FRCP Consultant Clinical Geneticist
Dr. Adam Schogger General Practitioner
Dr Sunil Raheja BM MRCPsych Retired Consultant Psychiatrist Learning Disabilities
Dr Lorna Green BMBS GP
Dr Ruaraidh MacKessack-Leitch MBChB DCH MRCGP General Practitioner
Dr. Stephen Brennan MBBS. MRCS. FRCP. Retired General Physician
Dr K Baxter Retired psychiatrist
Dr Chris Richards FRCPCH Consultant Paediatrician
Klaus Misch FRCP Consultant Dermatologist
Dr Max Hodges MBChB Consultant Anaesthetist
Dr Grace Rollason GP
Dr John Powell MBChB MRCGP Retired GP
Dr Stefan Gleeson BM BA MA(Med Ed) MSc(Health Econ) MRCPsych Consultant General Adult Psychiatrist, Clinical Lead CfPD
Dr DP Whitehouse MBChB; FRCP; DCH Consultant physician
Dr Anna Crozier BSc, MBBS, DRCOG, MRCGP, MSc, MRCPsych Consultant Psychiatrist in Psychotherapy
Dr Janet Nicholls Retired Consultant Paediatrician
Dr Tina Itani MBBS, MRCPsych, working with young people with complex needs in adolescent inpatient services Consultant Child and Adolescent Forensic Psychiatrist
Dr Tracy Mitchell BMBS MRCGP GP
Mr Naveen Cavale BSc(Hons), MBBS, MSc, FRCSEd(Plast) Consultant Plastic, Reconstructive & Cosmetic Surgeon
Dr M Battenfield Resident Doctor
Ms Helena Antoniadou FEBOPRAS Consultant Plastic Surgeon
Mr Ardit Begaj BSc MBChB MRCS Doctor
Mr E Fitzgerald O’Connor FRCS Consultant Surgeon
Mr Paul Wilson FRCS(Plast) Consultant Plastic Surgeon
Mr Charles Durrant MA MBBS BSc(hons) FRCS(plast) Consultant Plastic Surgeon
Mr Simon Heppell OBE, MB ChB FRCSEd FRCS(Plast) Consultant Plastic Surgeon
Miss Fiona Harper BSc MSc FRCS (Plast) Consultant Plastic Surgeon
Dr Nigel Barker BM FRCEM Retired A&E consultant
Dr Ruth Tunney MRCP MSc Specialist Registrar in Gastroenterology and Internal Medicine
Dr Anne McConville MBChB; MRCGP; FFPH Retired public health director
Dr Dennis Abadi MBBS BSc DRCOG
Dr Julie Maxwell MBBCh MRCPCH Retired Community Paediatrician
Dr Julie Sladden MBBS Retired Medical Practitioner
Dr Susan Davies MBBS, FRCPath Pathologist (retired)
Dr John Andrew Sutton MBBS, MD(London) Retired Cliniical Pharmacologist
Dr Matthew Thalanany MA, FRCP, FFPHM, FAFPHM Retired Director of Public Health
Dr Jasmin Khan-Singh FSRH, MIPM, MSc Child Health, Associate Specialist in Psychosexual Medicine & SRH (Rtd)
Dr Lewis Moonie MBChB MFCM MRCPsych MSc Retired
Dr Joseph Chrysostom MS(Gen Surg), FRCSEd Retired Associate Specialist
Dr Adam Wahba MBBS BSc PGCClinEd MRCS Neurosurgery Registrar
Cllr Dr Kate Usmar MBBS Cabinet member for adult services
Dr Helen Manson MBChB MRCGP DOccMed MMedEd Medical Ethicist
Dr Jonathan Rogers MBBChir PhD MRCP MRCPsych Clinical Lecturer in General Adult Psychiatry
Dr Carol Manwell Anaesthetics/Family Planning/ General Practice Retired
Dr Lisa Bundy Emergency Medicine Consultant
Dr Dylan Summers MB CHB General Practitioner
Doctor Mary Anne McCloskey MB,BCh.BAO.MRCGP Retired GP
Rev. Fr. James McTavish MA (Bioethics), MB, BChir, FRCS(Ed), STL Parish priest (Diocese of Westminster). Bioethicist.
Academics / Researchers / Scientists
Professor David Curtis, MD PhD FRCPsych Honorary Professor UCL and retired Consultant Psychiatrist
Prof. John Martin, MBChB, MD, FMedSci, FRCP, FESC, FAoP, Professor of Cardiovascular Medicine, University College London
Professor Michael Biggs, Professor of Sociology, Oxford
Professor David Pilgrim MSc MPsychol (Clin) PhD Clinical Psychologist
Dr Az Hakeem, MBBS MSc FRCPsych Consultant Psychiatrist and Group Analyst, Honorary Clinical Professor, UCL Medical School
Professor Ruth Parry PhD, Masters in Medical Science, previously an NHS Physiotherapist Healthcare scientist
Professor Alex Blakemore Professor of Human Genetics
Professor Jonathan Duckett MB ChB FRCOG MD Consultant Obstetrics and Gynaecology
Prof David Livermore BSc PhD Emeritus Professor of Medical Microbiology
Professor Raymond Tallis FRCP FMedSci Retired Geriatrician and Researcher and One-Time Chair of RCP Committee on Ethical Issues in Medicine
Dr Bernard Giusiano MD PhD Methodologist biostatistician
Mr David Britten Registered Member MBACP (Accred) former Senior Lecturer and Subject Co-Director, Counselling, York St John University
Dr Robert Paul Rowlands MBBS FRCPsych Consultant Psychiatrist, former Head of Yorkshire School of Psychiatry
Dr Trevor Stammers BSc, MBBS, MA, FHEA, FRCGP Retired Associate Professor of Medical Ethics and Law and former GP
Nurses / Midwives
Dr Sinead Helyar PhD MSc PG Dip BSc Registered Nurse
Anna Melamed Midwife. Researcher
Emma Gillard Registered Nurse
Mr Stephen Flute BN. NMP Clinical nurse specialist. (CAMHS)
Pauline Fox RMN NMP Retired Clinical Nurse Specialist
Mrs Deborah Sears Registered Nurse
Siobhan Cokell Registered Mental Health Nurse Community Mental Health Clinician Mental Health Educator
Mr Stephen Flute BN. NMP Clinical nurse specialist. Independent prescriber (CAMHS)
Siobhan Cokell Registered Mental Health Nurse Community Mental Health
Mrs S Ring Clinical Nurse Specialist in primary mental health care
Mrs Gill Thorpe Retired nurse
A Crawley Senior Midwife
Mrs Charlotte Huggins RM Midwife
Susan Frost Midwife Retired
Ms Elliot Psychiatric Nurse (retired)
Y Hunter Registered Nurse
Ms Julie Hotchkiss RN BSc MPH FFPH Consultant in Public Health (retired)
Dr Felicity Lillingston Integrated Medicine and Tropical Disease Specialist
Mrs Caroline Linkhorn Registered Nurse Senior Lead Nurse for Quality, Urgent and Emergency Care
Psychotherapists / Psychoanalysts
Ms Susan Evans Psychoanalytic Psychotherapist BPC, ex GIDS Tavistock clinical nurse specialist
Robert Withers, Jungian analyst (training analyst Society of Analytical Psychology member British Psychoanalytic Council) and former senior lecturer in the history and philosophy of medicine (University of Westminster)
Terry Patterson MBACP Acc Clinical Supervisor, Chair of Thoughtful Therapists
Stella O’Malley, MA, Psychotherapist
Mrs Jennie Cummings-Knight Psychotherapist, MA, RMBACP, PGCE, Accred. Mediator
Mr Antoine Bowes Psychotherapist
Mr Nick Karr BA, CQSW, PGDip Psych MA MBACP Psychotherapist
Mr Alasdair Stoked UKCP reg Psychoanalytic Psychotherapist
Ms AnnaMaria Minogue UKCP Integrative Psychotherapist
Mrs Sonia Lucas Psychotherapist
Michele Morphitis BSc (Econ) MA Psychoanalytic Studies NHS Tavistock and Portman MBACP Psychotherapist
Catherine Williamson Psychodynamic Psychotherapist
Mr Alasdair Stokeld UKCP reg Psychoanalytic Psychotherapist
Ms Anna Maria Minogue UKCP Integrative Psychotherapist
Matthew Leckie BACP registered Psychotherapist
Mr James Caspian Psychotherapist
Mrs Susan Forbes MSc PGdip CBT Psychotherapist
Ursula Barnes MA (Cantab), MSc, BACP, UKCP Psychotherapist
Mr Marcus Evans Fellow institute of psychoanalysis Psychoanalyst
Diane Drory Psychologist psychoanalyst, specialised in children and adolescents
Mrs Deborah Short MA, UKCP Reg. Psychotherapist
Dr Russel Ayling Clinical psychologist and psychoanalyst
Ms Leslie Hayes MSW, Accredited CBT Psychotherapist Cognitive Behavioural Therapist
Ms Merryn Jones Psychotherapist Psychotherapist
Ms Alice Bondi Psychotherapist (retired)
Ms Rosamund Willliams Msc; Dip Psychotherapy Retired Psychotherapist
Mrs Carolyn Polunin MSc Int Psych Integrative Psychotherapist
Ms Jackie Charbit-Middleton Psychoanalytic Psychoanalytic Psychotherapist
Ms Philippa Marx Psychotherapist
Ms Jean Dowton 20 years working as a psychotherapist with a very wide range of people, including those with gender confusion. UKCP Accredited Psychotherapist
Mr Anthony Cantle Fellow of The Institute of Psychoanalysis, Founder and former Director of Open Door, Adolescent Consultation Service, Haringey. Retired Psychoanalyst
Mrs Ruth McCall Fellow, British Psychoanalytical Society Psychoanalyst
Ms Charlotte Disley MA (Cantab.) MA (HIP) UKCP reg. Psychotherapist
Ms Lindsey Robinson Psychotherapist
Lynne Evans Psychotherapist
Ms N Masani BACP Accred Somatic Psychotherapist
Ms Mica Bobsin Psychotherapist (retired)
Mr Mark Smith MSc PGdip BA hons Cognitive Behavioural Therapist
Jessica Goldfinch Psychological Therapist (RtT/ CBT)
Alex Maunder Taylor MBACP Integrative Therapist
Dr Emily Hodgson Masters degree in Core Process Psychotherapy Retired
Philip Stokoe Psychoanalyst & Organisational Consultant
Mrs F Robinson Accredited BABCP psychotherapist and Registered BACP Counsellor & Psychotherapist (Retired)
Mrs Olivia Coningham-Rolls MSc MBACP (Accred) Child & Adolescent Psychotherapist
Ms Wendy Durell PgDip AT, MA, PGCE Art Therapist
Clinical Psychologists
Dr John Higgon Cons. Clin. Neuropsychologist
Dr Celia Sadie MA, MSc, MPhil, DClinPsy Consultant Clinical Psychologist
Dr Anne Woodhouse D Clin Psy Consultant Clinical Psychologist
Dr Libby Barnardo Clinical Psychologist
Dr R Woolrich Clinical Psychologist
Mrs Deanne Jade GMBsS Psychologist Director, National Centre for Eating Disorders
Ms Carolyn Brown BAHons M.Ed MAppSci Retired Deputy Principal Psychologist
Dr Rachel Woolrich D Clin Psy Clinical Psychologist
Ms Stacy Barnes MS Registered Psychologist
Ms H L Catt MCIPD, BSC Counselling Psychologist
Ms Alison Teal Psychologist and Therapist
Dr L Dixon Consultant Clinical Psychologist
Ms Jennifer Cutler Consultant Forensic Psychologist
Mr Brian Stanley BSc.(Hons) MSc MBA C.Psychol C.Sci AFBPsS Consultant Clinical Psychologist (retired)
Dr Natalie Roberts D.Clin. Psych. Consultant clinical psychologist
Counsellors
Ms Kate Morrissey Counsellor
Ben Sears Counsellor
Ms Amber Redish Therapeutic counsellor with neurodivergent adults and young people
Lucy Beney Integrative Counsellor (former School Counsellor)
Ms Mary Garner BACP accred Counsellor
Kelly Oliver Dougall Counsellor
Vanessa Haynes Counsello
Rachel Maisey MA MBACP (Accredited) Counsellor
Lyn Poole MBACP Counsellor
Elizabeth Tuohy Counsellor
Ms D Evans Counsellor
Allied Health Professionals
Sinéad O’Halloran MRPharmSGB Consultant Pharmacist Critical Care
Mrs Elaine Miller Fellow of the Chartered Society of Physiotherapy Pelvic health physio
Liz Panton MRCSLT Retired Speech & Language Therapist and NHS Manager
Mrs Mary Edwards Physiotherapist
Lyndsay Smith BSC Diagnostic Radiography and PGD ultrasound Advanced Practitioner Sonographer
Mrs Ann Stevens RHV, RN 40 years. Health Visitor
Sandie Smith Radiographer Retired
Mr Thomas Ellery Physiotherapy assistant
Ms Susan Moffat Retired health promotion specialist
Social Work/Education/Safeguarding
Maggie Mellon M.Sc., CQSW, Dip. Child Protection Social Worker
Ms Mary Howden Social Worker (Retired) Former Head of Education and Workforce Development SSSC
Ms M Siviter DipSW 33yrs local authority Social Worker (Ret’d)
Barbara Santos MSW, and BECE Family Social Worker
Ms Elizabeth Gillanders Bachelor Social Work Social Worker
Ms Linda Devlin Service Manager Camhs Retired social worker and family therapist
Margot Henery retired social worker
Jane McLenachan Child Protection social worker & social work educator. Retired.
Ms Susan Harrison MASW CQSW Social Worker – retired
Ms Angela Callery B.A.(Hons) Social Sciences. P.G.C.E. Retired Secondary School Teacher
Ms Caroline Natzler Retired teacher
Miss Katie Pert PGCE Teaching Assistant
Non-UK clinicians
Professor Celine Masson Professor of Psychology (France)
Associate Professor Michael McDonough MB BS, Dip Tox, MAddSc, FAChAM-RACP (retired) Clinical Director of Drug Services (South Africa)
MD, PhD Siri Fuglem Berg pediatric bioethics, anesthesiology, immunology, public health Chief medical officer public health (Norway)
Madame Potin-Kahn Dominique Psychologue psychothérapeute (France)
Diane Drory psychologist psychoanalist spécialised in children and adolescents (France)
Marie-Laure Roman Psychologist (France)
Mrs Inger Richardson B App Sci MRT, Grad Dip Sono Med sonographer (Australia)
Dr Rita Marta Adult, children and adolescents Psychoanalyst, 30 years working with adolescents Clinical Psychologist and Psychoanalyst (Portugal)
Mrs. Jill Lindqvist Gibson Psychologist/Psychoanalyst IPA (Sweden)
Christopher Gibson Child and adolescent psychoanalyst (Sweden)
Dr Frédéric Missenard Psychiatrist (France)
Assoc. Prof. Peter Parry MBBS, PhD, FRANZCP, Cert Child Adolescent Psychiatry (RANZCP) Consultant Child & Adolescent Psychiatrist (New Zealand)
Dr Madeleine Ní Dhálaigh MICGP General Practitioner (Ireland)
Dr. Julia Mason Pediatrician (USA)
Associate Professor Michael Sladden MBChB, MAE, FACD, MRCP, MRCGP, DRCOG Dermatologist (Australia)
Dr Daniel S Halpérin Paediatrician FMH, past privat-docent University of Geneva, (Switzerland)
Dr. Patrick Hunter MD MSc General Pediatrician Assistant Clinical Professor Florida State University (USA)
Dr David Kardachi Senior Emergency Department and Ward GP VMO Senior Emergency Department and Ward GP VMO (Australia)
Doctor Xavier-Laurent Salvador Maître De Conférence HDR (France)
Dr Frank New MB BS FRANZCP FFPMANZCA Consultant Psychiatrist Specialist Pain Medicine Physician (Retired) (Australia)
Dr Andrew Orr Retired general practitioner (Australia)
Dr David Chee MBBS, DipRACOG, FRACGP GP (Australia)
Mr Adam Greenbaum MBBS MBA PhD FRCS (Plast) FEBOPRAS FACS Consultant Plastic Surgeon (New Zealand)
Dr Eckhard Piegsa MD FRCPCH Paediatric Neurologist (Germany)
Add your name here: Sign the letter to Wes Streeting